Presentations Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Medicenna Therapeutics Corp. - Corporate Presentation Q3 2023 Past Events May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to March 26 - March 27, 2020 6th Annual Immuno-Oncology Innovation Forum (Virtual) Go to March 25, 2020 at 10:00 AM EDT IL-2 Superkine, MDNA19, Non-Human Primate Study Go to January 17 - January 19, 2020 AlphaNorth Capital Investment Conference Go to January 13 - January 15, 2020 Biotech Showcase Conference Go to December 11, 2019 at 10:30 AM EST Inaugural Glioblastoma Drug Development Annual Summit Go to Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Current page 13
May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to
